| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new era of antibody discovery: an in-depth review of AI-driven approaches
|
Cheng, Jin
|
|
|
29 |
6 |
p.
|
artikel
|
| 2 |
A retrospective regulatory analysis of FDA recalls carried out by pharmaceutical companies from 2012 to 2023
|
Patel, Ravi
|
|
|
29 |
6 |
p.
|
artikel
|
| 3 |
Artificial intelligence in drug discovery: A mirage or an oasis?
|
Sethi, Aaftaab
|
|
|
29 |
6 |
p.
|
artikel
|
| 4 |
AXL receptor as an emerging molecular target in colorectal cancer
|
De Rosa, Lucia
|
|
|
29 |
6 |
p.
|
artikel
|
| 5 |
Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor treatment
|
Zhang, Linxi
|
|
|
29 |
6 |
p.
|
artikel
|
| 6 |
From GPUs to AI and quantum: three waves of acceleration in bioinformatics
|
Schmidt, Bertil
|
|
|
29 |
6 |
p.
|
artikel
|
| 7 |
Growing value of data standardization: Allotrope Foundation Connect Workshop Proceedings
|
Kayser, Henning
|
|
|
29 |
6 |
p.
|
artikel
|
| 8 |
How health technology assessment can help to address challenges in drug repurposing: a conceptual framework
|
Abu-Zahra, Teebah
|
|
|
29 |
6 |
p.
|
artikel
|
| 9 |
How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons
|
KP Jayatunga, Madura
|
|
|
29 |
6 |
p.
|
artikel
|
| 10 |
Hypoxia-induced pulmonary hypertension in adults and newborns: implications for drug development
|
Ahmed, Abu Shufian Ishtiaq
|
|
|
29 |
6 |
p.
|
artikel
|
| 11 |
Making good decisions in early drug discovery
|
Sandrin, Virginie
|
|
|
29 |
6 |
p.
|
artikel
|
| 12 |
Multifaceted therapeutic applications of biomimetic nanovaccines
|
Chheda, Dev
|
|
|
29 |
6 |
p.
|
artikel
|
| 13 |
Premix technologies for drug delivery: manufacturing, applications, and opportunities in regulatory filing
|
Ashokbhai, Makka Krupali
|
|
|
29 |
6 |
p.
|
artikel
|
| 14 |
Recent advances in the development of DprE1 inhibitors using AI/CADD approaches
|
Chen, Kepeng
|
|
|
29 |
6 |
p.
|
artikel
|
| 15 |
Strengthening Molecular Glues: Design Strategies for Improving Thalidomide Analogs as Cereblon Effectors and Anticancer Agents
|
Nutt, Michael J
|
|
|
29 |
6 |
p.
|
artikel
|
| 16 |
Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics
|
Bao, Qichao
|
|
|
29 |
6 |
p.
|
artikel
|
| 17 |
Text summarization with ChatGPT for drug labeling documents
|
Ying, Lan
|
|
|
29 |
6 |
p.
|
artikel
|
| 18 |
The IDMP Ontology – A Catalyst to Unleash the Potential of AI and Accelerate Data-Driven Decisions with Industry-Wide Standards
|
Elz, Sheila R.
|
|
|
29 |
6 |
p.
|
artikel
|
| 19 |
The present state and challenges of active learning in drug discovery
|
Wang, Lei
|
|
|
29 |
6 |
p.
|
artikel
|
| 20 |
Thyroid receptor β: A promising target for developing novel anti-androgenetic alopecia drugs
|
Zhi, Jia
|
|
|
29 |
6 |
p.
|
artikel
|
| 21 |
TPP-based conjugates: potential targeting ligands
|
Batheja, Sanya
|
|
|
29 |
6 |
p.
|
artikel
|
| 22 |
Unleashing the power of generative AI in drug discovery
|
Gangwal, Amit
|
|
|
29 |
6 |
p.
|
artikel
|
| 23 |
Vaginal drug delivery system: A promising route of drug administration for local and systemic diseases
|
Subi, M. Tamil Mani
|
|
|
29 |
6 |
p.
|
artikel
|
Tijdschrift beschrijving